Lupus Therapeutics partners with Takeda on phase 1 trial to evaluate TAK-079 as potential new therapy for lupus March 1, 2019https://www.ptcommunity.com/wire/lupus-therapeutics-partners-takeda-phase-1-trial [Read more…] about Lupus Therapeutics partners with Takeda on phase 1 trial to evaluate TAK-079 as potential new therapy for lupus
